Boceprevir: a novel nonstructural 3 (NS3) protease inhibitor for the treatment of chronic hepatitis C infection
about
Direct anti-HCV agentsFine mapping of murine antibody responses to immunization with a novel soluble form of hepatitis C virus envelope glycoprotein complex.Safety of direct antiviral agents in the management of hepatitis C.Establishment of a novel triple-transgenic mouse: conditionally and liver-specifically expressing hepatitis C virus NS3/4A protease.
P2860
Boceprevir: a novel nonstructural 3 (NS3) protease inhibitor for the treatment of chronic hepatitis C infection
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Boceprevir: a novel nonstructu ...... chronic hepatitis C infection
@en
Boceprevir: a novel nonstructural 3
@nl
type
label
Boceprevir: a novel nonstructu ...... chronic hepatitis C infection
@en
Boceprevir: a novel nonstructural 3
@nl
prefLabel
Boceprevir: a novel nonstructu ...... chronic hepatitis C infection
@en
Boceprevir: a novel nonstructural 3
@nl
P2860
P356
P1476
Boceprevir: a novel nonstructu ...... chronic hepatitis C infection
@en
P2093
Paul Y Kwo
P2860
P304
P356
10.1177/1756283X11436317
P577
2012-05-01T00:00:00Z